A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US

Stewart J Tepper, Aaron Jenkins, Simon Dagenais, Carl Henriksen, Lucy Abraham, Feng Dai, Karin Hygge Blakeman, Astrid Gendolla

Open source

DOI
10.1177/03331024261447187
Published
2026-06
Container
Cephalalgia
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/03331024261447187,
  title = {A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US},
  author = {Stewart J Tepper and Aaron Jenkins and Simon Dagenais and Carl Henriksen and Lucy Abraham and Feng Dai and Karin Hygge Blakeman and Astrid Gendolla},
  year = {2026},
  journal = {Cephalalgia},
  doi = {10.1177/03331024261447187},
  url = {https://doi.org/10.1177/03331024261447187}
}

RIS

TY  - JOUR
TI  - A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US
AU  - Stewart J Tepper
AU  - Aaron Jenkins
AU  - Simon Dagenais
AU  - Carl Henriksen
AU  - Lucy Abraham
AU  - Feng Dai
AU  - Karin Hygge Blakeman
AU  - Astrid Gendolla
PY  - 2026
JO  - Cephalalgia
DO  - 10.1177/03331024261447187
UR  - https://doi.org/10.1177/03331024261447187
ER  - 

APA

Tepper, S. J., Jenkins, A., Dagenais, S., Henriksen, C., Abraham, L., Dai, F., Blakeman, K. H., & Gendolla, A. (2026). A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US. Cephalalgia. https://doi.org/10.1177/03331024261447187

Source records